Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours.
Saved in:
| Title: | Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours. |
|---|---|
| Authors: | Poret, Benjamin1,2,3 (AUTHOR) Marc-Andre.Bonin@USherbrooke.ca, Desrues, Laurence1,2,4 (AUTHOR) laurence.desrues@univ-rouen.fr, Bonin, Marc-André3 (AUTHOR) Richard.Leduc@USherbrooke.ca, Pedard, Martin1,4 (AUTHOR) martin.pedard@univ-rouen.fr, Dubois, Martine1,4 (AUTHOR) martine.dubois@univ-rouen.fr, Leduc, Richard3 (AUTHOR), Modzelewski, Romain2,4 (AUTHOR) pierre.vera@chb.unicancer.fr, Decazes, Pierre2,4 (AUTHOR) pierre.bohn@chb.unicancer.fr, Morin, Fabrice1,2,4 (AUTHOR) fabrice.morin@univ-rouen.fr, Vera, Pierre2,4 (AUTHOR), Castel, Hélène1,4 (AUTHOR) helene.castel@univ-rouen.fr, Bohn, Pierre2,4 (AUTHOR), Gandolfo, Pierrick1,4 (AUTHOR) |
| Source: | Biomolecules (2218-273X). Mar2020, Vol. 10 Issue 3, p471. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2218273X |
|---|---|
| DOI: | 10.3390/biom10030471 |
